|
Summary Information: BELLUS Health Inc. Common Shares NASDAQ:BLU |
admin@troach.net |
Our Main Pages Stocks.TRoach.Net TRoach.Org TRoach.Net |
_Description: BELLUS Health is a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of chronic cough and other hypersensitization-related disorders. The Company's product candidate, BLU-5937, is being developed for the treatment of chronic cough and chronic pruritus.
__The following are links to various summary and news pages for __BELLUS Health Inc. Common Shares [ BLU ]. __Note: Some Links might not have information for the company. |
|